Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 19.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Celgene Corporation, EISAI, Inc., Foundation Medicine, Inc., Genentech, Genomic Health Inc., Lilly, and Novartis Pharmaceuticals Corporation.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
Physicians’ Education Resource ®, LLC.
All rights reserved.

13th Annual International Congress on the Future of Breast Cancer®

13th Annual International Congress on the Future of Breast Cancer®


Agenda

Thursday, July 17, 2014
7:30 AM Registration and Continental Breakfast  
Morning Session Moderator: Joyce A. O'Shaughnessy, MD
8:00 AM Welcome and Introductions
8:05 AM Highlights of Clinical Breast Cancer Management in 2013/2014 Kathy Albain, MD
Evolving Management Considerations in ER+ Breast Cancer  
8:45 AM Determining the Risk of Late Recurrence Joseph Sparano, MD
9:25 AM Clinical Implications of Promiscuous Steroid Hormone Receptors Carol Lange, PhD
9:50 AM ESR1 Mutations in MBC: Iatrogenic or Clonal Outgrowth?
Faculty has not granted permission to post this presentation
Suzanne A W Fuqua, PhD
10:15 AM Break  
10:40 AM Selecting Patients and Managing Toxicity with mTOR Inhibitors Hope S. Rugo, MD
11:05 AM Are Adjuvant Bisphosphonates a New Standard of Care? Adam Brufsky, MD, PhD, FACP
11:30 AM Novel Inhibitors of Endocrine Therapy Resistance Lori J. Goldstein, MD
12:00 PM Case Discussions from Faculty Practices: Adjuvant Premenopausal High Risk; Indolent MBC ER+; Extended Adjuvant Therapy All Faculty
12:30 PM Break for Lunch (lunch on own)  
Afternoon Session - Dilemmas in the Management of Locoregional Disease Moderator: Lori J. Pierce, MD, FASTRO
1:50 PM Intraoperative Radiotherapy: A New Standard of Care? David E. Wazer, MD, FASTRO
2:15 PM Does Biology Dictate Risk of Locoregional Recurrence? Eleftherios Mamounas, MD, MPH, FACS
2:40 PM Break  
3:05 PM New Insights into Surgical Management of Locoregional Disease David M. Euhus, MD, FACS
3:30 PM Can Radiation Replace Surgery in Some Patients?
Faculty has not granted permission to post this presentation
Lori J. Pierce, MD, FASTRO
3:55 PM Do Patients with De Novo Metastatic Disease Benefit from Locoregional Therapy? Seema A. Khan, MD
4:20 PM Who Does Not Need Radiation Therapy? Reshma Jagsi, MD 
4:45 PM Case Discussions from Faculty Practices: De Novo MBC; Axillary RT vs surgery; High Risk Node Negative Disease All Faculty
5:15 PM Adjourn  
5:30 PM Welcome Reception (Exhibit Hall)  
 
Friday, July 18, 2014
7:00 AM Continental Breakfast  
Sunrise Session - An Open Case Discussion Moderator: Joyce A. O'Shaughnessy, MD
Faculty: David M. Euhus, MD, FACS; Reshma Jagsi, MD; Frankie Ann Holmes, MD, FACP
7:30 AM Ask the Experts: Controversial Cases From Your Practices  
8:00 AM Discussion  
8:20 AM Sunrise Session Adjourn  
Morning Session  
8:30 AM Welcome and Introductions  
Evolving Management of HER2+ Breast Cancer Moderator: Frankie Ann Holmes, MD, FACP
8:35 AM Is Preoperative Therapy the Standard of Care? Frankie Ann Holmes, MD, FACP
9:00 AM Clinical Utility of HER2 Tyrosine Kinase Inhibitors Joyce O'Shaughnessy, MD
9:25 AM Novel Insights into Adjuvant Therapy Ruth O'Regan, MD
9:50 AM PIK3CA Mutations in HER2+ Breast Cancer Sara Hurvitz, MD
10:10 AM Break  
10:35 AM Sequencing Therapies in HER2+ Metastatic Breast Cancer Debu Tripathy, MD
11:05 AM Case Discussions from Faculty Practices: PI3K-mutant; Brain Mets; T2N0 Disease  
Diagnostic Approaches to the High Risk Patient  
11:30 AM Clinical Utility of Community-Based Molecular Profiling Joyce O'Shaughnessy, MD
12:00 PM Question and Answer  
12:15 PM Break for Lunch (lunch on own)  
Afternoon Session: Exceptional Responders with Metastatic Breast Cancer: Case Presentations Moderator: Joyce O'Shaughnessy, MD;
Faculty: Frankie Ann Holmes, MD, FACP, Ruth O'Regan, MD, Debu Tripathy, MD
1:50 PM Faculty Case Presentations and Panel Discussion  
2:40 PM Break  
3:00 PM Faculty Case Presentations and Panel Discussion  
4:30 PM Adjourn  
 
Saturday, July 19, 2014
7:30 AM Continental Breakfast  
Morning Session  
8:30 AM Welcome and Introductions  
Triple-Negative Breast Cancer: Are We Making Progress? Moderator: Joyce A. O'Shaughnessy, MD
8:45 AM Preoperative Platinum: A New Standard of Care? William Sikov, MD
9:15 AM Novel Preoperative Therapy Hypotheses Jenny Chang, MD
9:40 AM Moving Beyond BRCA1/2 Germline Testing Claudine Isaacs, MD
10:05 AM Break  
10:30 AM Obesity, Fats and Sugar: The Evolving Science David M. Euhus, MD, FACS
10:55 AM Metastatic TNBC: Are Cytotoxic Agents Subtype-Specific? Joyce O'Shaughnessy, MD
11:20 AM Incorporating Imaging into Locoregional Management Nola M. Hylton, PhD
11:45 AM Case Discussions from Faculty Practices  
12:15 PM Break for Lunch (lunch on own)  
Afternoon Session: Health Care Reform: Implications for Oncology Practice Moderator: Joyce A. O'Shaughnessy, MD
1:30 PM Cancer Care and Oncology Practice: Now and in 2015 Linda Bosserman, MD, FACP
Breast Cancer Molecular Tumor Board: Case Presentations Joyce O’Shaughnessy, MD; William Sikov, MD; Jenny Chang, MD; Claudine Isaacs, MD
2:00 PM Faculty Case Presentations and Panel Discussion
Faculty has not granted permission to post this presentation
 
3:40 PM Closing Comments Joyce O'Shaughnessy, MD
3:45 PM Adjourn  







Become a Member

Forgot Password?
Filter By